The Gaudette and Pins labs have developed a method to produce discrete fibrin microthreads, which can be seeded with human mesenchymal stem cells (hMSCs) and used as a suture to enhance the efficiency and localization of cell delivery.
This technology is based on bioresorbable fibrin microthreads which are attached to surgical needles, allowing for the efficient delivery of cells with the same ease as employing a conventional suture. Multiple different cell types may be cultured on and delivered, offering utility for a broad array of cell therapies.
Part of The Investigator's Annexe program.